| scholarly article | Q13442814 |
| P433 | issue | 5 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 713-722 | |
| P577 | publication date | 1996-05-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines | |
| P478 | volume | 39 |
| Q81972128 | A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis |
| Q81786169 | A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China |
| Q24794291 | A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]. |
| Q34313736 | A prospective outcomes study of Swanson metacarpophalangeal joint arthroplasty for the rheumatoid hand |
| Q33937792 | Assessing physical activity in persons with rheumatoid arthritis using accelerometry |
| Q31935428 | COX-2 inhibitors in rheumatoid arthritis |
| Q87256372 | Can new diagnostic criteria of rheumatoid arthritis really make an early diagnosis? --A case report of early diagnosis and treatment of early rheumatoid arthritis with Chinese medicine |
| Q34730722 | Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis |
| Q41934162 | Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients |
| Q33914378 | Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain |
| Q36819270 | Clinical joint inactivity predicts structural stability in patients with established rheumatoid arthritis |
| Q28066250 | Combination therapy with biologic agents in rheumatic diseases: current and future prospects |
| Q77050434 | Corticosteroid prescribing in rheumatoid arthritis and psoriatic arthritis |
| Q36054167 | Cost of prescribed NSAID-related gastrointestinal adverse events in elderly patients |
| Q55313980 | Cutaneous toxicity of oral low-dose methotrexate. |
| Q48027852 | Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention |
| Q24188058 | Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis |
| Q33761844 | Diclofenac/misoprostol. Pharmacoeconomic implications of therapy |
| Q35605663 | Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study |
| Q35554539 | Effect of Curcuma zedoaria Rosc root extracts on behavioral and radiology changes in arthritic rats |
| Q39304368 | Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial |
| Q36062038 | Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis |
| Q33684274 | Etanercept: a review of its use in rheumatoid arthritis |
| Q34991484 | Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis |
| Q41166897 | Extra-articular manifestations of seronegative and seropositive rheumatoid arthritis |
| Q35622929 | GCF Resistin As A Novel Marker in Patients with Chronic Periodontitis and Rheumatoid Arthritis |
| Q43682732 | Gastrointestinal-related healthcare resource usage associated with a fixed combination of diclofenac and misoprostol versus other NSAIDs |
| Q34460609 | Immunomodulation of Autoimmune Arthritis by Herbal CAM |
| Q64917344 | Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data. |
| Q42711164 | Individualized stepped care of chronic illness |
| Q92502816 | Infrared Thermography Sensor for Disease Activity Detection in Rheumatoid Arthritis Patients |
| Q33770534 | Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation |
| Q35826170 | Leflunomide in active rheumatoid arthritis: a prospective study in daily practice |
| Q55540665 | Leflunomide in active rheumatoid arthritis: a prospective study in daily practice. |
| Q33826225 | Leflunomide: a review of its use in active rheumatoid arthritis |
| Q36067667 | Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors |
| Q34669149 | Monitoring healthy people 2010 arthritis management objectives: education and clinician counseling for weight loss and exercise |
| Q34059371 | Oral versus topical NSAIDs in rheumatic diseases: a comparison |
| Q53395110 | Predicting Response to Therapy for Autoimmune and Inflammatory Diseases Using a Folate Receptor-Targeted Near-Infrared Fluorescent Imaging Agent. |
| Q35861284 | Public health impact of risk factors for physical inactivity in adults with rheumatoid arthritis |
| Q84606152 | Quantitative analysis of vascularization in the finger joints in patients with rheumatoid arthritis using three-dimensional volumetric ultrasonography with power Doppler |
| Q33954543 | Rheumatology: 7. Basics of therapy |
| Q33954115 | Rheumatology: 8. Advanced therapy. |
| Q34277837 | Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis |
| Q73533377 | Role of mucus reduction and luminal acid elevation in increased susceptibility of stomach to nonsteroidal antiinflammatory drug-induced injury in arthritic rats |
| Q51773490 | Semi-quantitative analysis of rheumatoid finger joint synovitis using power Doppler ultrasonography: when to perform follow-up study after treatment consisting mainly of antitumor necrosis factor alpha agent. |
| Q36741413 | Severity index for rheumatoid arthritis and its association with health care costs and biologic therapy use in Turkey |
| Q51804775 | Significance of anti-CCP antibodies in modification of 1987 ACR classification criteria in diagnosis of rheumatoid arthritis. |
| Q62322819 | Strengthening exercises to improve hand strength and functionality in rheumatoid arthritis with hand deformities: a randomized, controlled trial |
| Q79334350 | Synovial membrane enhancement and bone erosion by magnetic resonance imaging for prediction of radiologic progression in patients with early rheumatoid arthritis |
| Q79721915 | The significance of platelet activation in rheumatoid arthritis |
| Q35070450 | Understanding emerging treatment paradigms in rheumatoid arthritis |
| Q37583037 | Utilization patterns of disease-modifying antirheumatic drugs in elderly rheumatoid arthritis patients |
| Q44679527 | [Drug therapy of rheumatoid arthritis]. |
| Q52903653 | [How closely does rheumatology treatment follow the guidelines?: ambition and reality]. |
| Q73164408 | [Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis] |
Search more.